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Background
Approximately 30% of AIDS-related lymphomas (ARL)
are associated with infection by the EBV, and about 4%
by the KSHV/HHV-8. It is likely that if other lymphoma-
genic pathogens exist, these associations would occur in
the context of ARL. The advent of high throughput
sequencing provides a unique opportunity to address this
question. High throughput sequencing, followed by com-
putational subtraction of human sequences was used for
enrichment of candidate pathogenic sequences.
Methods
Eleven primary tissues of ARL have been used to generate
cDNA libraries. Out of these six were frozen specimens
and five were formalin-fixed paraffin-embedded (FFPE).
These libraries were subjected to high throughput Illumina
sequencing to generate 30-60 million 76bp paired-end
sequence reads per sample. Quality filtered reads were
analyzed using our automated pipeline, PathSeq,w h i c h
carries out several subtraction steps involving alignments
to i) human genome sequence databases; ii) human tran-
scriptome sequence databases; and iii) other vertebrate
sequence databases. Residual sequence reads were then
compared with microbial databases, either individually or
as part of de novo assembled contigs.
Results
Using both frozen and formalin-fixed paraffin-embedded
(FFPE) tissues, we have identified unique sequences pre-
viously unassociated with hematological cancers and
inflammatory diseases. In addition, our pathogen discovery
pipeline works with both transcriptome and whole gen-
ome sequencing (WGS) data, and it is applicable to data
across all high throughput sequencing platforms. Most
notably, we are able to detect as low as 1 viral sequence
per billion total sequences for WGS data, a sign of the sen-
sitivity of our method. Among the known pathogens, we
found 12423 sequences corresponding to EBV in the one
case where the presence of this virus was also documented
by EBER in situ hybridization. Three additional cases that
were EBER-negative revealed EBV sequences, in the range
of 3 to 351 reads, suggesting that the virus was present in
tumor-infiltrating cells, rather than in the lymphoma.
Eight cases had HIV sequences ranging from 1 to 403
reads, and one case had a single read corresponding to
KSHV.
Conclusions
We have developed an integrated pipeline, PathSeq,f o r
pathogen discovery in both frozen and FFPE tissues using
a high throughput sequencing-based computational sub-
traction process. The presence of >10,000 reads in the
known EBV-positive case confirms the effectiveness of the
method. Specific EBV and HIV sequences were seen ema-
nating from tumor-infiltrating cells that will shed light on
expression patterns of these viruses in this cellular
compartment.
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